OBJECTIVE: To determine the extent to which the community-directed approach used in onchocerciasis control in Africa could effectively and efficiently provide integrated delivery of other health interventions. METHODS: A three-year experimental study was undertaken in 35 health districts from 2005 to 2007 in seven research sites in Cameroon, Nigeria and Uganda. Four trial districts and one comparison district were randomly selected in each site. All districts had established ivermectin treatment programmes, and in the trial districts four other established interventions - vitamin A supplementation, use of insecticide-treated nets, home management of malaria and short-course, directly-observed treatment for tuberculosis patients - were progressively incorporated into a community-directed intervention (CDI) process. At the end of each of the three study years, we performed quantitative evaluations of intervention coverage and provider costs, as well as qualitative assessments of the CDI process. FINDINGS: With the CDI strategy, significantly higher coverage was achieved than with other delivery approaches for all interventions except for short-course, directly-observed treatment. The coverage of malaria interventions more than doubled. The district-level costs of delivering all five interventions were lower in the CDI districts, but no cost difference was found at the first-line health facility level. Process evaluation showed that: (i) participatory processes were important; (ii) recurrent problems with the supply of intervention materials were a major constraint to implementation; (iii) the communities and community implementers were deeply committed to the CDI process; (iv) community implementers were more motivated by intangible incentives than by external financial incentives. CONCLUSION: The CDI strategy, which builds upon the core principles of primary health care, is an effective and efficient model for integrated delivery of appropriate health interventions at the community level in Africa.
RCT Entities:
OBJECTIVE: To determine the extent to which the community-directed approach used in onchocerciasis control in Africa could effectively and efficiently provide integrated delivery of other health interventions. METHODS: A three-year experimental study was undertaken in 35 health districts from 2005 to 2007 in seven research sites in Cameroon, Nigeria and Uganda. Four trial districts and one comparison district were randomly selected in each site. All districts had established ivermectin treatment programmes, and in the trial districts four other established interventions - vitamin A supplementation, use of insecticide-treated nets, home management of malaria and short-course, directly-observed treatment for tuberculosispatients - were progressively incorporated into a community-directed intervention (CDI) process. At the end of each of the three study years, we performed quantitative evaluations of intervention coverage and provider costs, as well as qualitative assessments of the CDI process. FINDINGS: With the CDI strategy, significantly higher coverage was achieved than with other delivery approaches for all interventions except for short-course, directly-observed treatment. The coverage of malaria interventions more than doubled. The district-level costs of delivering all five interventions were lower in the CDI districts, but no cost difference was found at the first-line health facility level. Process evaluation showed that: (i) participatory processes were important; (ii) recurrent problems with the supply of intervention materials were a major constraint to implementation; (iii) the communities and community implementers were deeply committed to the CDI process; (iv) community implementers were more motivated by intangible incentives than by external financial incentives. CONCLUSION: The CDI strategy, which builds upon the core principles of primary health care, is an effective and efficient model for integrated delivery of appropriate health interventions at the community level in Africa.
Authors: Jan H F Remme; Erik Blas; Lester Chitsulo; Philippe M P Desjeux; Howard D Engers; Thomas P Kanyok; Jane F Kengeya Kayondo; Deborah W Kioy; Vasanthapuram Kumaraswami; Janis K Lazdins; Paul P Nunn; Ayoade Oduola; Robert G Ridley; Yeya T Toure; Fabio Zicker; Carlos M Morel Journal: Trends Parasitol Date: 2002-10
Authors: Joseph C Okeibunor; Michael K Ogungbemi; Martin Sama; Sesso C Gbeleou; Ukam Oyene; Jan H F Remme Journal: Trop Med Int Health Date: 2004-08 Impact factor: 2.622
Authors: Margaret C Baker; Deborah A McFarland; Manuel Gonzales; Mary Janet Diaz; David H Molyneux Journal: Int J Health Plann Manage Date: 2007 Oct-Dec
Authors: M Homeida; E Braide; E Elhassan; U V Amazigo; B Liese; B Benton; M Noma; D Etya'alé; K Y Dadzie; O O Kale; A Sékétéli Journal: Ann Trop Med Parasitol Date: 2002-03
Authors: A Sékétéli; G Adeoye; A Eyamba; E Nnoruka; P Drameh; U V Amazigo; M Noma; F Agboton; Y Aholou; O O Kale; K Y Dadzie Journal: Ann Trop Med Parasitol Date: 2002-03
Authors: Joseph Kamgno; Hugues C Nana-Djeunga; Sébastien D Pion; Cédric B Chesnais; Amy D Klion; Charles D Mackenzie; Thomas B Nutman; Michel Boussinesq Journal: Int Health Date: 2018-03-01 Impact factor: 2.473
Authors: Jan H F Remme; Taghreed Adam; Francisco Becerra-Posada; Catherine D'Arcangues; Michael Devlin; Charles Gardner; Abdul Ghaffar; Joachim Hombach; Jane F K Kengeya; Anthony Mbewu; Michael T Mbizvo; Zafar Mirza; Tikki Pang; Robert G Ridley; Fabio Zicker; Robert F Terry Journal: PLoS Med Date: 2010-11-16 Impact factor: 11.069
Authors: Kevin C Kobylinski; Haoues Alout; Brian D Foy; Archie Clements; Poom Adisakwattana; Brett E Swierczewski; Jason H Richardson Journal: Am J Trop Med Hyg Date: 2014-07-28 Impact factor: 2.345
Authors: Pitchaya P Indravudh; Katherine Fielding; Moses K Kumwenda; Rebecca Nzawa; Richard Chilongosi; Nicola Desmond; Rose Nyirenda; Melissa Neuman; Cheryl C Johnson; Rachel Baggaley; Karin Hatzold; Fern Terris-Prestholt; Elizabeth L Corbett Journal: PLoS Med Date: 2021-05-11 Impact factor: 11.069
Authors: Pauline N M Mwinzi; Susan P Montgomery; Chrispin O Owaga; Mariam Mwanje; Erick M Muok; John G Ayisi; Kayla F Laserson; Erick M Muchiri; W Evan Secor; Diana M S Karanja Journal: Parasit Vectors Date: 2012-08-31 Impact factor: 3.876
Authors: Pitchaya P Indravudh; Katherine Fielding; Linda A Sande; Hendramoorthy Maheswaran; Saviour Mphande; Moses K Kumwenda; Richard Chilongosi; Rose Nyirenda; Cheryl C Johnson; Karin Hatzold; Elizabeth L Corbett; Fern Terris-Prestholt Journal: BMJ Glob Health Date: 2021-07